These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2820786)
1. Effect of lonidamine on the utilization of 14C-labeled glucose by human astrocytoma cells. Paggi MG; Zupi G; Fanciulli M; Del Carlo C; Giorno S; Laudonio N; Silvestrini B; Caputo A; Floridi A Exp Mol Pathol; 1987 Oct; 47(2):154-65. PubMed ID: 2820786 [TBL] [Abstract][Full Text] [Related]
2. Effect of lonidamine on human malignant gliomas: biochemical studies. Paggi MG; Carapella CM; Fanciulli M; Del Carlo C; Giorno S; Zupi G; Silvestrini B; Caputo A; Floridi A J Neurooncol; 1988 Nov; 6(3):203-9. PubMed ID: 3225640 [TBL] [Abstract][Full Text] [Related]
3. Modulation of glycolysis in neuroepithelial tumors. Floridi A; Paggi MG; Fanciulli M J Neurosurg Sci; 1989; 33(1):55-64. PubMed ID: 2674359 [TBL] [Abstract][Full Text] [Related]
4. Effect of the antitumor drug lonidamine on glucose metabolism of adriamycin-sensitive and -resistant human breast cancer cells. Fanciulli M; Valentini A; Bruno T; Citro G; Zupi G; Floridi A Oncol Res; 1996; 8(3):111-20. PubMed ID: 8823807 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification. Ben-Yoseph O; Lyons JC; Song CW; Ross BD J Neurooncol; 1998 Jan; 36(2):149-57. PubMed ID: 9525814 [TBL] [Abstract][Full Text] [Related]
6. Effect of lonidamine on protein synthesis in neoplastic cells. Floridi A; Delpino A; Nista A; Feriozzi R; Marcante ML; Silvestrini B; Caputo A Exp Mol Pathol; 1985 Jun; 42(3):293-305. PubMed ID: 3996552 [TBL] [Abstract][Full Text] [Related]
7. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Floridi A; Paggi MG; D'Atri S; De Martino C; Marcante ML; Silvestrini B; Caputo A Cancer Res; 1981 Nov; 41(11 Pt 1):4661-6. PubMed ID: 7306982 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies. Ben-Horin H; Tassini M; Vivi A; Navon G; Kaplan O Cancer Res; 1995 Jul; 55(13):2814-21. PubMed ID: 7796408 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine. Guo L; Shestov AA; Worth AJ; Nath K; Nelson DS; Leeper DB; Glickson JD; Blair IA J Biol Chem; 2016 Jan; 291(1):42-57. PubMed ID: 26521302 [TBL] [Abstract][Full Text] [Related]
10. Potentiation of lonidamine and diazepam, two agents acting on mitochondria, in human glioblastoma treatment. Miccoli L; Poirson-Bichat F; Sureau F; Bras Gonçalves R; Bourgeois Y; Dutrillaux B; Poupon MF; Oudard S J Natl Cancer Inst; 1998 Sep; 90(18):1400-6. PubMed ID: 9747871 [TBL] [Abstract][Full Text] [Related]
11. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. Floridi A; Paggi MG; Marcante ML; Silvestrini B; Caputo A; De Martino C J Natl Cancer Inst; 1981 Mar; 66(3):497-9. PubMed ID: 6937706 [TBL] [Abstract][Full Text] [Related]
12. Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: 31P and 13C nuclear magnetic resonance studies. Vivi A; Tassini M; Ben-Horin H; Navon G; Kaplan O Breast Cancer Res Treat; 1997 Mar; 43(1):15-25. PubMed ID: 9065595 [TBL] [Abstract][Full Text] [Related]
13. Glucose metabolism in adriamycin-sensitive and -resistant LoVo human colon carcinoma cells. Fanciulli M; Bruno T; Castiglione S; Del Carlo C; Paggi MG; Floridi A Oncol Res; 1993; 5(9):357-62. PubMed ID: 8038456 [TBL] [Abstract][Full Text] [Related]
14. Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine. Fanciulli M; Bruno T; Giovannelli A; Gentile FP; Di Padova M; Rubiu O; Floridi A Clin Cancer Res; 2000 Apr; 6(4):1590-7. PubMed ID: 10778993 [TBL] [Abstract][Full Text] [Related]
15. Effect of lonidamine on the aerobic glycolysis of normal and phytohemagglutinin-stimulated human peripheral blood lymphocytes. Nista A; De Martino C; Malorni W; Marcante ML; Silvestrini B; Floridi A Exp Mol Pathol; 1985 Apr; 42(2):194-205. PubMed ID: 3156759 [TBL] [Abstract][Full Text] [Related]
16. Energy metabolism of normal and lonidamine-treated Sertoli cells of rats. Floridi A; Marcante ML; D'Atri S; Feriozzi R; Menichini R; Citro G; Cioli V; De Martino C Exp Mol Pathol; 1983 Feb; 38(1):137-47. PubMed ID: 6832337 [TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effect of lonidamine on a human glioblastoma multiforme cell line. Iacopino F; Sica G; Macrì P; Paggi MG; Scerrati M; Roselli R; Marchetti P; Della Cuna GR; Marini L J Neurosurg Sci; 1990; 34(3-4):193-7. PubMed ID: 1965900 [TBL] [Abstract][Full Text] [Related]
18. The effect of lonidamine (LND) on radiation and thermal responses of human and rodent cell lines. Raaphorst GP; Feeley MM; Danjoux CE; Martin L; Fisher B; Maroun J; DeSanctis AJ Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):509-15. PubMed ID: 1995536 [TBL] [Abstract][Full Text] [Related]
19. Modulation of adriamycin uptake by lonidamine in Ehrlich ascites tumor cells. Floridi A; Gambacurta A; Bagnato A; Bianchi C; Paggi MG; Silvestrini B; Caputo A Exp Mol Pathol; 1988 Dec; 49(3):421-31. PubMed ID: 3197818 [TBL] [Abstract][Full Text] [Related]
20. Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose. Miwa H; Shikami M; Goto M; Mizuno S; Takahashi M; Tsunekawa-Imai N; Ishikawa T; Mizutani M; Horio T; Gotou M; Yamamoto H; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M Oncol Rep; 2013 May; 29(5):2053-7. PubMed ID: 23440281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]